Barinthus Biotherapeutics plc (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

0.5621

-0.0369 (-6.16%)

At close: Aug 10, 2026, 4:00 PM EDT

0.5600

-0.0021 (-0.37%)

After-hours: Aug 10, 2026, 4:06 PM EDT

Barinthus Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	14.97	0.8	44.7	0.27
Revenue Growth	-	-	1766.46%	-98.21%	16580.22%	-94.44%
Gross Profit	-	-	14.97	0.8	44.7	0.27
Selling, General & Admin	22.44	-40.83	-29.67	39.84	6.39	25.12
Research & Development	16.84	-25.56	-42.24	44.87	42.35	20.37
Other Operating Expenses	4.45	-5.17	-13.39	-	-	-
Total Operating Expenses	43.73	-71.57	-85.29	84.72	48.74	45.49
Operating Income	-43.73	-70.56	-67.97	-83.91	-4.04	-45.22
Interest Income	1.57	1.96	2.68	2.88	3.1	0
Interest Expense	-0.05	-0.05	-0.05	-0.03	-0.02	-2.67
Other Non-Operating Income (Expense)	0.23	2.02	4.12	4.54	1.81	-3.25
Total Non-Operating Income (Expense)	1.75	3.92	6.74	7.39	4.89	-5.92
Pretax Income	-41.97	-66.63	-61.23	-76.52	0.85	-51.14
Provision for Income Taxes	-0.17	-0.18	-0.04	-3.08	-4.47	-0.03
Net Income	-41.81	-66.46	-61.18	-73.45	5.32	-51.11
Minority Interest in Earnings	-0.04	-0.03	-0.11	-0.1	-0.02	-0.25
Net Income to Common	-41.77	-66.43	-61.07	-73.35	5.34	-50.87
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	41	41	39	39	38	37
Shares Outstanding (Diluted)	41	41	39	39	38	37
Shares Change	1.85%	3.00%	1.82%	2.55%	1.33%	367.17%
EPS (Basic)	-1.02	-1.64	-1.55	-1.90	0.14	-1.37
EPS (Diluted)	-1.02	-1.64	-1.55	-1.90	0.14	-1.37
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-26.43	-46.04	-28.04	-56.34	-20.57	-33.73
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.65	-1.14	-0.71	-1.46	-0.55	-0.91
Gross Margin	-	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-	-454.07%	-10463.10%	-9.04%	-16873.50%
Profit Margin	-	-	-408.73%	-9157.98%	11.90%	-19071.60%
FCF Margin	-	-	-187.34%	-7024.69%	-46.01%	-12585.40%
EBITDA	-40.24	-64.71	-62.17	-78.49	0.28	-44.62
EBITDA Margin	-	-	-415.32%	-9786.16%	0.63%	-16648.90%
EBIT	-43.73	-70.56	-67.97	-83.91	-4.04	-45.22
EBIT Margin	-	-	-454.07%	-10463.10%	-9.04%	-16873.50%
Effective Tax Rate	0.40%	0.26%	0.07%	4.02%	-526.00%	0.05%

SEC Filings: 10-K · 10-Q